KalVista Pharmaceuticals, Inc.
Biotechnology · Healthcare
Board Member
2025-10-01–present
KalVista Pharmaceuticals, Inc.
Board Member
KalVista Pharmaceuticals, Inc.
Equibles does not estimate personal net worth.
Nancy Stuart is recorded as Board Member at KalVista Pharmaceuticals, Inc. since October 1, 2025. KalVista Pharmaceuticals, Inc. reported in an 8-K filed June 11, 2026 that Nancy Stuart resigned as member of the Company's board of directors. KalVista Pharmaceuticals, Inc. reported in an 8-K filed October 2, 2025 that Nancy Stuart was appointed Compensation Committee of the Board, effective October 1, 2025. KalVista Pharmaceuticals, Inc. reported in an 8-K filed October 17, 2022 that Nancy Stuart was appointed Chair of the Nominating and Corporate Governance Committee, effective October 13, 2022. KalVista Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company's board of directors and all committees thereof”
“The Board also approved Ms. Stuart's appointment to the Compensation Committee of the Board, effective immediately.”
KalVista Pharmaceuticals, Inc.
SEC 8-K
2025-10-01–present
KalVista Pharmaceuticals, Inc.
Board Member
SEC 8-K
2025-10-01–present
KalVista Pharmaceuticals, Inc.
Board Member
Proxy statement
Start not stated–2026-06-11
KalVista Pharmaceuticals, Inc.
Biotechnology · Healthcare
Board Member
2025-10-01–present
KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc.